Glioblastoma: Vascular Habitats Detected at Preoperative Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Survival.
暂无分享,去创建一个
Luis Martí-Bonmatí | Javier Juan-Albarracín | Juan M García-Gómez | Elies Fuster-Garcia | Ángel Alberich-Bayarri | Fernando Aparici-Robles | L. Martí-Bonmatí | Á. Alberich-Bayarri | J. M. García-Gómez | Antonio Revert-Ventura | J. Juan-Albarracín | E. Fuster-García | Alexandre Pérez-Girbés | A. Pérez-Girbés | F. Aparici-Robles | A. Revert-Ventura
[1] Steven D Chang,et al. Magnetic resonance perfusion image features uncover an angiogenic subgroup of glioblastoma patients with poor survival and better response to antiangiogenic treatment , 2016, Neuro-oncology.
[2] Douglas C. Miller,et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. , 2008, Radiology.
[3] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[4] J P B O'Connor,et al. Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours. , 2011, The British journal of radiology.
[5] Scott N. Hwang,et al. Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. , 2014, Radiology.
[6] Glyn Johnson,et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. , 2002, Radiology.
[7] J. Raizer,et al. Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study. , 2010, Radiology.
[8] Luke Macyszyn,et al. Pattern analysis of dynamic susceptibility contrast-enhanced MR imaging demonstrates peritumoral tissue heterogeneity. , 2014, Radiology.
[9] Susan M. Chang,et al. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. , 2005, AJNR. American journal of neuroradiology.
[10] Dafna Ben Bashat,et al. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study. , 2014, European journal of radiology.
[11] M R Segal,et al. Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2008, American Journal of Neuroradiology.
[12] Leif Østergaard,et al. Principles of cerebral perfusion imaging by bolus tracking , 2005, Journal of magnetic resonance imaging : JMRI.
[13] Wanyong Shin,et al. Quantitative cerebral MR perfusion imaging: Preliminary results in stroke , 2010, Journal of magnetic resonance imaging : JMRI.
[14] David Gutman,et al. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. , 2013, Radiology.
[15] G Johnson,et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.
[16] A. Kyritsis,et al. Mechanisms of angiogenesis in gliomas , 2006, Journal of Neuro-Oncology.
[17] José V. Manjón,et al. Automated Glioblastoma Segmentation Based on a Multiparametric Structured Unsupervised Classification , 2015, PloS one.
[18] A. Bjørnerud,et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. , 2008, Radiology.
[19] Helena Borges,et al. Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. , 2011, Life sciences.
[20] Sanjeev Chawla,et al. Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma. , 2012, Neuro-oncology.
[21] Gang Wang,et al. Diffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumors , 2016, Radiation Oncology.
[22] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[23] Luis Martí-Bonmatí,et al. Quantitative MR perfusion parameters related to survival time in high-grade gliomas , 2013, European Radiology.
[24] T. Hirai,et al. Prognostic Value of Perfusion MR Imaging of High-Grade Astrocytomas: Long-Term Follow-Up Study , 2008, American Journal of Neuroradiology.
[25] Glyn Johnson,et al. Comparison of region‐of‐interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas , 2007, Journal of magnetic resonance imaging : JMRI.
[26] Juan Miguel García-Gómez,et al. An Online Platform for the Automatic Reporting of Multi-parametric Tissue Signatures: A Case Study in Glioblastoma , 2016, BrainLes@MICCAI.
[27] D. Zagzag,et al. Mechanisms of glioma-associated neovascularization. , 2012, The American journal of pathology.
[28] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[29] B. Rosen,et al. Tracer arrival timing‐insensitive technique for estimating flow in MR perfusion‐weighted imaging using singular value decomposition with a block‐circulant deconvolution matrix , 2003, Magnetic resonance in medicine.
[30] Carlos Sáez,et al. Stability metrics for multi-source biomedical data based on simplicial projections from probability distribution distances , 2017, Statistical methods in medical research.
[31] S. Su,et al. IDH mutations in glioma and acute myeloid leukemia. , 2010, Trends in molecular medicine.
[32] J. Lemée,et al. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. , 2015, Neuro-oncology.
[33] Linda Knutsson,et al. Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities , 2010, Magnetic Resonance Materials in Physics, Biology and Medicine.
[34] Jianhui Zhong,et al. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma. , 2010, Radiology.
[35] Simona Marzi,et al. Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation , 2012, Journal of experimental & clinical cancer research : CR.
[36] E. Liouta,et al. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients , 2016, Neuroradiology.